quinazolines has been researched along with Hypertension, Renovascular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alter, ML; Chaykovska, L; Hocher, B; Hohmann, M; Klein, T; Kraft, R; Kutil, B; Reichetzeder, C; Tsuprykov, O; von Websky, K | 1 |
| Chen, SY; Deng, SX; Li, D; Li, YJ; Liao, DF; Qin, XP; Ren, JF; Tian, HH; Zeng, SY; Zheng, YB | 1 |
| Brandes, RP; Busse, R; Geiger, H; Jung, O; Pedrazzini, T; Schreiber, JG | 1 |
| Chen, QQ; Deng, HW; Hu, GY; Li, D; Li, YJ; Luo, D; Qin, XP; Zeng, SY; Zhang, Z | 1 |
| Baldoli, E; Barone, D; Sala, A; Winters, G | 1 |
5 other study(ies) available for quinazolines and Hypertension, Renovascular
| Article | Year |
|---|---|
Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Collagen Type I; Constriction, Pathologic; Cystatin C; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Fibrosis; Heart; Hypertension, Renovascular; Kidney; Linagliptin; Lipoproteins, LDL; Male; Oxidative Stress; Purines; Quinazolines; Random Allocation; Rats; Rats, Wistar; Surgical Instruments; Telmisartan | 2013 |
Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Carboxypeptidases; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Renovascular; Hypertrophy; Indole Alkaloids; Kallikreins; Losartan; Male; Mesenteric Arteries; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation | 2009 |
gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcholine; Angiotensin II; Animals; Antioxidants; Aorta; Bacterial Toxins; Cardiomyopathy, Hypertrophic; Cytochromes b; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; ErbB Receptors; Glycoproteins; Hypertension, Renovascular; Indoles; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Organ Culture Techniques; Polyethylene Glycols; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Superoxide Dismutase; Superoxides; Tyrphostins; Vasodilation; Vasodilator Agents | 2004 |
Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Vessels; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Renovascular; Hypertrophy; Hypotension; Indole Alkaloids; Losartan; Male; Mesenteric Artery, Superior; Muscle, Smooth, Vascular; Quinazolines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Vasodilator Agents | 2007 |
Synthesis, in vitro [3H]prazosin displacement, and in vivo activity of 3-aryl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines, a new class of antihypertensive agents.
Topics: Animals; Brain; Cats; Chemical Phenomena; Chemistry; Dogs; Hypertension; Hypertension, Renovascular; Male; Mice; Prazosin; Pyrazoles; Pyridines; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Synaptosomes | 1985 |